Skip to main content
. 2023 Feb 20;136(2):194–206. doi: 10.1097/CM9.0000000000002554

Table 3.

IOD (mean) of Cx43 in the biopsy of CML patients and healthy donors.

Patients Gender Age (years) Diagnosis IOD (mean) Donor Gender Age (years) IOD (mean)
Patient 1 M 20 CML 623.91 Donor 1 F 53 2185.22
Patient 2 M 22 CML 1710.89 Donor 2 F 44 2166.52
Patient 3 F 28 CML 561.67 Donor 3 F 61 5368.76
Patient 4 F 54 CML 2002.27 Donor 4 F 20 7650.07
Patient 5 F 58 CML 2935.38 Donor 5 M 37 5184.72
Patient 6 M 75 CML 4271.85 Donor 6 M 52 7020.30
Patient 7 F 26 CML 1975.45 Donor 7 M 32 8386.25
Patient 8 M 64 CML 2239.86 Donor 8 M 48 3190.83
Patient 9 F 35 CML 6473.38 Donor 9 F 55 2056.72
Patient 10 M 57 CML 631.65 Donor 10 F 25 2532.66

CML: Chronic myeloid leukemia; Cx43: Connexin 43; F: Female; IOD: Integral optical intensity; M: Male.